Ernexa Therapeutics Inc. Revenue Breakdown
No Revenue Breakdown for ERNA on this site yet.
- 2024-12-31: Others Not split by product in the filing$582.00K100.00%; Total revenue $582.00K.
- 2023-12-31: Total revenue $68.00K.
- 2022-12-31: Total revenue $0.00.
- 2020-12-31: Others Not split by product in the filing$5.80M100.00%; Total revenue $5.80M.
Source checked: the stored Revenue Breakdown page for ERNA.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2024-12-31 | Not split by product in the filing $582.00K 100.00% | $582.00K |
| 2023-12-31 | $68.00K | |
| 2022-12-31 | $0.00 | |
| 2020-12-31 | Not split by product in the filing $5.80M 100.00% | $5.80M |
| 2019-12-31 | Not split by product in the filing $19.81M 100.00% | $19.81M |
| 2018-12-31 | Not split by product in the filing $23.34M 100.00% | $23.34M |
| 2017-12-31 | Not split by product in the filing $21.27M 100.00% | $21.27M |
| 2016-12-31 | Not split by product in the filing $22.31M 100.00% | $22.31M |
| 2015-12-31 | Not split by product in the filing $24.52M 100.00% | $24.52M |
| 2014-12-31 | Not split by product in the filing $26.05M 100.00% | $26.05M |
| 2013-12-31 | Not split by product in the filing $23.75M 100.00% | $23.75M |
| 2012-12-31 | Not split by product in the filing $24.06M 100.00% | $24.06M |
| 2011-12-31 | Not split by product in the filing $23.87M 100.00% | $23.87M |
| 2010-12-31 | Not split by product in the filing $25.31M 100.00% | $25.31M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2024-12-31 | Not split by product $1.00K 100.00% | $1.00K |
| 2024-09-30 | Not split by product $487.00K 100.00% | $487.00K |
| 2024-06-30 | Not split by product $47.00K 100.00% | $47.00K |
| 2024-03-31 | Not split by product $47.00K 100.00% | $47.00K |
| 2023-12-31 | Not split by product $17.00K 100.00% | $17.00K |
| 2023-09-30 | Not split by product $51.00K 100.00% | $51.00K |
| 2023-03-31 | Not split by product $0.00 | $0.00 |
| 2022-12-31 | Not split by product $0.00 | $0.00 |
| 2022-09-30 | Not split by product $0.00 | $0.00 |
| 2020-12-31 | Not split by product $1.18M 100.00% | $1.18M |
| 2020-09-30 | Not split by product $1.48M 100.00% | $1.48M |
| 2020-06-30 | Not split by product $754.00K 100.00% | $754.00K |
| 2020-03-31 | Not split by product $2.39M 100.00% | $2.39M |
| 2019-12-31 | Not split by product $5.17M 100.00% | $5.17M |
| 2019-09-30 | Not split by product $4.58M 100.00% | $4.58M |
| 2019-06-30 | Not split by product $5.23M 100.00% | $5.23M |
| 2019-03-31 | Not split by product $4.83M 100.00% | $4.83M |
| 2018-12-31 | Not split by product $5.92M 100.00% | $5.92M |
| 2018-09-30 | Not split by product $6.00M 100.00% | $6.00M |
| 2018-06-30 | Not split by product $5.65M 100.00% | $5.65M |
| 2018-03-31 | Not split by product $5.76M 100.00% | $5.76M |
| 2017-12-31 | Not split by product $5.30M 100.00% | $5.30M |
| 2017-09-30 | Not split by product $5.20M 100.00% | $5.20M |
| 2017-06-30 | Not split by product $5.55M 100.00% | $5.55M |
| 2017-03-31 | Not split by product $5.23M 100.00% | $5.23M |
| 2016-12-31 | Not split by product $5.98M 100.00% | $5.98M |
| 2016-09-30 | Not split by product $5.44M 100.00% | $5.44M |
| 2016-06-30 | Not split by product $5.41M 100.00% | $5.41M |
| 2016-03-31 | Not split by product $5.48M 100.00% | $5.48M |
| 2015-12-31 | Not split by product $6.52M 100.00% | $6.52M |
| 2015-09-30 | Not split by product $6.08M 100.00% | $6.08M |
| 2015-06-30 | Not split by product $6.19M 100.00% | $6.19M |
| 2015-03-31 | Not split by product $5.73M 100.00% | $5.73M |
| 2014-12-31 | Not split by product $6.75M 100.00% | $6.75M |
| 2014-09-30 | Not split by product $6.00M 100.00% | $6.00M |
| 2014-06-30 | Not split by product $6.87M 100.00% | $6.87M |
| 2014-03-31 | Not split by product $6.42M 100.00% | $6.42M |
| 2013-12-31 | Not split by product $6.58M 100.00% | $6.58M |
| 2013-09-30 | Not split by product $5.53M 100.00% | $5.53M |
| 2013-06-30 | Not split by product $5.53M 100.00% | $5.53M |
| 2013-03-31 | Not split by product $6.12M 100.00% | $6.12M |
| 2012-12-31 | Not split by product $5.93M 100.00% | $5.93M |
| 2012-09-30 | Not split by product $6.05M 100.00% | $6.05M |
| 2012-06-30 | Not split by product $6.01K 100.00% | $6.01K |
| 2012-03-31 | Not split by product $6.07M 100.00% | $6.07M |
| 2011-12-31 | Not split by product $6.10M 100.00% | $6.10M |
| 2011-09-30 | Not split by product $5.87M 100.00% | $5.87M |
| 2011-06-30 | Not split by product $6.07K 100.00% | $6.07K |
| 2011-03-31 | Not split by product $6.00M 100.00% | $6.00M |
| 2010-12-31 | Not split by product $6.34M 100.00% | $6.34M |
| 2010-09-30 | Not split by product $6.50M 100.00% | $6.50M |
| 2010-06-30 | Not split by product $6.19M 100.00% | $6.19M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |